Navigation Links
Platelet-rich Plasma Enhances Bone and Tissue Growth for Dental Implants
Date:12/3/2009

CHICAGO, Dec. 3 /PRNewswire/ -- An exciting treatment gaining acceptance in orthopedics and sports medicine, called platelet-rich plasma therapy (PRP), is showing strong potential for accelerated healing of dental implant procedures, according to a prominent dental researcher and editor of the Journal of Oral Implantology.

James Rutkowski, DMD, PhD, reported at the recent annual scientific meeting of the American Academy of Implant Dentistry that platelet-rich plasma therapy can accelerate bone and tissue growth and wound healing and help assure long-term success of dental implant placements.

"What could be better than using the body's own regenerative powers to grow bone and soft tissue safely and quickly? For dental implant procedures, PRP treatments can jump start bone growth and implant adherence in just two weeks, which cuts down the time between implant placement and affixing the permanent crown," said Rutkowski.

Platelet-rich plasma is obtained from a small sample of the patient's own blood. It is centrifuged to separate platelet growth factors from red blood cells. The concentration of platelets triggers rapid growth of new bone and soft tissue. "There is very little risk because we are accelerating the natural process in which the body heals itself," said Rutkowski. "PRP speeds up the healing process at the cellular level, and there is virtually no risk for allergic reaction or rejection because we use the patient's own blood."

Rutkowski noted that some orthopedic physicians have been using PRP with success for painful and hard to treat injuries like tennis elbow, tendonitis and ligament damage. An avid Pittsburgh Steelers fan, Rutkowski couldn't resist mentioning that PRP was used in 2009 pre-game Super Bowl treatment for two Steeler players (Heinz Ward and Troy Polamalo), and both were instrumental in the team winning its 6th Super Bowl.

For dental surgery applicat
'/>"/>

SOURCE American Academy of Implant Dentistry
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Platelet-Rich Plasma: Does It Work?
2. Platelet-rich plasma: Does it work?
3. Significantly Higher Percentage of Hetastarch Recipients Underwent a Surgical Procedure Than Those Receiving Albumin/Plasma Protein Fraction
4. Plasma protein Therapies Association Focuses Attention on Donors and Facilities
5. Grifols Honors Texas Plasma Donors During Plasma Protein Therapies Month
6. Plasma Protein Therapeutics Association Urges CMS For Appropriate Hospital Outpatient Drug Reimbursement
7. PEAK Surgical Introduces PEAK PlasmaBlade(TM) TnA
8. Platelet Rich Plasma Therapy (PRP) Accelerates Healing of Joint Injuries, Osteoarthritis Pain
9. PEAK Surgical Announces First Use of PEAK PlasmaBlade(TM) in Europe
10. PEAK Surgical Announces Positive Fascia Incision Healing Results From Preclinical Study of PEAK PlasmaBlade(TM) for Gynecologic Surgery
11. Research Shows Plasma Exchange Helps Multiple Sclerosis Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... LEXINGTON, Ky. (April 21, 2014) -- A group ... of Medicine and the Sanders-Brown Center on Aging ... on depression and neuropsychological function in Parkinson,s disease ... Psychiatry Research , the study, which assessed cognitive ... found that the dopamine replacement therapy commonly used ...
(Date:4/18/2014)... researchers have been awarded two-year grants for their work ... month. Of the 110 initial submissions to the new ... only four projects were funded, three of which are ... M.D., Ph.D.; G. William Wong, Ph.D.; and Elias Zambidis, ... oncology, will use his $500,000 proof of principle grant ...
(Date:4/18/2014)... new study in the American Journal of Preventive ... reveals a recurring pattern that could be leveraged to ... San Diego State University, the Santa Fe Institute, Johns ... searches (searches that included the term healthy and were ... from 2005 to 2012. They found that on average, ...
(Date:4/17/2014)... in non-cancerous prostate tissue may have nearly twice the ... no inflammation, according to results of a new study ... Center. , The link between persistent inflammation and cancer ... cancer those with a Gleason score between 7 ... aggressive and rapidly growing prostate cancers. , "What we,ve ...
(Date:4/17/2014)... published today in PLOS Pathogens , children who ... common can mount an immune response to infection with ... bouts of high fever and illness and partially control ... findings may help researchers develop future interventions that prevent ... , Each year, approximately 200 million cases of malaria ...
Breaking Medicine News(10 mins):Health News:Treating depression in PD patients: New research 2Health News:New research shows people are thinking about their health early in the week 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study sheds light on how the immune system protects children from malaria 2
... Alan Mozes HealthDay Reporter , MONDAY, Sept. 19 ... common, non-infectious diseases -- cancer, diabetes, heart disease, lung disease ... million in treatment costs and lost wages. ... Burden of Non-communicable Diseases," released by the World Economic Forum ...
... pioneered a new combination treatment for prostate cancer. The ... will now be tested for efficacy in a second phase. ... and aggressive form of prostate cancer which has spread to ... developed. It combines traditional chemotherapy treatments with two doses ...
... Massachusetts health care reform designed to bolster employer-based insurance ... unable to afford it, the uninsured in Massachusetts remain ... by researchers at Harvard Medical School just published online ... The 2006 comprehensive health care reform was designed ...
... 17 (HealthDay News) -- ,Paralyzed veterans who learned to ... new study suggests. Researchers brought 10 paralyzed veterans ... May for a four-day scuba certification course. Before ... psychological tests, measuring muscle spasticity, motor control and sensitivity ...
... 16 (HealthDay News) -- People who carry a certain ... a lower five-year survival rate after coronary artery bypass ... to better treat and ensure the survival of these ... from Duke University Medical Center in Durham, N.C. ...
... September 16, 2011 Researchers have shown for the first ... by binding to and rendering inert protein p53, a known ... Texas Medical Branch may lead to treatments for a range ... appears in the current print issue of the Journal ...
Cached Medicine News:Health News:Global Toll of 'Non-Communicable Diseases' -- $47 Trillion by 2030 2Health News:Global Toll of 'Non-Communicable Diseases' -- $47 Trillion by 2030 3Health News:Global Toll of 'Non-Communicable Diseases' -- $47 Trillion by 2030 4Health News:Queen's pioneers prostate cancer breakthrough 2Health News:Uninsured patients in Mass. still mainly the working poor, despite state's health reform 2Health News:Uninsured patients in Mass. still mainly the working poor, despite state's health reform 3Health News:Scuba Diving May Help Paralyzed Vets 2Health News:Gene Variant May Raise Death Risk After Heart Bypass 2Health News:Researchers identify potential molecular target to prevent growth of cancer cells 2
(Date:1/15/2014)... NEW YORK , Jan. 15, ... new market research report is available ... Global Markets and Technologies for ... on Routes of Administration ...
(Date:1/15/2014)... 2014  A novel wearable injector slightly larger than an Oreo ... to self-inject prescription drugs in the large doses required to ... autoimmune deficiencies, and genetic disorders.  An emerging ... 2018, according to analysts.   Many of these drugs will require ...
(Date:1/14/2014)... AUSTIN, Texas , Jan. 14, 2014  Luminex Corporation (Nasdaq: ... report results for the fourth quarter of 2013 on Monday, ... scheduled for release after the close of trading. ... a conference call to discuss the operating highlights and financial ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3
... Inc. (NASDAQ: QCOR ) today announced ... to its Board of Directors.  Dr. Whitcup is ... Chief Scientific Officer at Allergan, Inc.  In that ... research and development organization, including medical affairs, drug ...
... Feb. 16, 2012 OPKO Health, Inc. and ChromaDex ... a strategic alliance pursuant to which ChromaDex has licensed ... health care technologies for distribution and business development throughout ... commercialized are BluScience™ ( www.bluscience.com ), ChromaDex,s ...
Cached Medicine Technology:Questcor Pharmaceuticals Appoints Scott M. Whitcup, M.D., to Board of Directors 2Questcor Pharmaceuticals Appoints Scott M. Whitcup, M.D., to Board of Directors 3Questcor Pharmaceuticals Appoints Scott M. Whitcup, M.D., to Board of Directors 4OPKO Health, Inc. Invests in ChromaDex® Corp. 2OPKO Health, Inc. Invests in ChromaDex® Corp. 3OPKO Health, Inc. Invests in ChromaDex® Corp. 4OPKO Health, Inc. Invests in ChromaDex® Corp. 5
... can code the charge while completing a chart ... away from office, both directly feeding the charge ... Encounter Form/Superbill, data entry can be done with ... payments are posted by reflecting open item charges, ...
The HearTwave system is the original stand-alone Microvolt T-Wave Alternans (MTWA) testing platform....
... that a second mirror adds, then you may ... features the same 1.5x magnification as the G-1 ... and 64 respectively. Available in standard (flange) or ... "Flanged" model for laser use. Provides ...
... The AFX (Air Fluid ... image lens designed for use ... addition to its use as ... lens, the low profile and ...
Medicine Products: